Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinz Kohler

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
International Reviews of Immunology|September 17, 2004
Structured therapy interruption (STI) and deceptive imprintingHeinz Kohler
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2017
Natural Antibodies: Next Steps Toward Translational InvestigationHeinz Kohler
Immunotherapy|March 1, 2013
Homophilic antibodies as immunotherapeuticsHeinz Kohler
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|December 15, 2022
What Can We Learn from Research with Monoclonal Antibody 1F7?Heinz Kohler
International Reviews of Immunology|September 17, 2004
AIDS vaccines--a continuing struggleHeinz Kohler
Vaccine|June 3, 2015
Novel vaccine concept based on back-boost effect in viral infectionHeinz Kohler
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|September 9, 2024
Immune Jumping in Autoimmune Long-CovidHeinz Kohler
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|February 3, 2021
The Impact of the Hybridoma Technology on the R&D of Idiotypic AntibodiesHeinz Kohler
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2002
Enhancing tumor targeting and apoptosis using noncovalent antibody homodimersYunfeng Zhao, Heinz Kohler
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|January 29, 2021
How IvIg Can Mitigate Covid-19 Disease: A Symmetrical Immune Network ModelHeinz Kohler, Srini Kaveri
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
International Reviews of Immunology|September 17, 2004
Structured therapy interruption (STI) and deceptive imprintingHeinz Kohler
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2017
Natural Antibodies: Next Steps Toward Translational InvestigationHeinz Kohler
Immunotherapy|March 1, 2013
Homophilic antibodies as immunotherapeuticsHeinz Kohler
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|December 15, 2022
What Can We Learn from Research with Monoclonal Antibody 1F7?Heinz Kohler
International Reviews of Immunology|September 17, 2004
AIDS vaccines--a continuing struggleHeinz Kohler
Vaccine|June 3, 2015
Novel vaccine concept based on back-boost effect in viral infectionHeinz Kohler
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|September 9, 2024
Immune Jumping in Autoimmune Long-CovidHeinz Kohler
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|February 3, 2021
The Impact of the Hybridoma Technology on the R&D of Idiotypic AntibodiesHeinz Kohler
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2002
Enhancing tumor targeting and apoptosis using noncovalent antibody homodimersYunfeng Zhao, Heinz Kohler
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|January 29, 2021
How IvIg Can Mitigate Covid-19 Disease: A Symmetrical Immune Network ModelHeinz Kohler, Srini Kaveri
Pageof 4